老虎证券

BUZZ-Australia's InhaleRx gains on securing funding for depression therapy SRX-25

Reuters
2025/12/04
BUZZ-Australia's InhaleRx gains on securing funding for depression therapy SRX-25

** Shares of Australia's InhaleRx IRX.AX rise as much as 7.7% to A$0.027, posting their biggest intraday pct gain since November 20

** Medical device maker gets A$12.6 million ($8.32 million)in additional funding to support development of SRX-25, an oral fixed-dose combination therapy targeting treatment-resistant depression

** Stock has fallen 19.4% this year, including day's moves

($1 = 1.5145 Australian dollars)

(Reporting by Roshan Thomas in Bengaluru)

((Roshan.Thomas@thomsonreuters.com;))

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10